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abstract
 
In this study we examined the expression of RyR subtypes and the role of RyRs in neurotransmitter-
and hypoxia-induced Ca
 
2
 
 
 
 release and contraction in pulmonary artery smooth muscle cells (PASMCs). Under
perforated patch clamp conditions, maximal activation of RyRs with caffeine or inositol triphosphate receptors
(IP
 
3
 
Rs) with noradrenaline induced equivalent increases in [Ca
 
2
 
 
 
]
 
i
 
 and Ca
 
2
 
 
 
-activated Cl
 
 
 
 currents in freshly
isolated rat PASMCs. Following maximal IP
 
3
 
-induced Ca
 
2
 
 
 
 release, neither caffeine nor chloro-
 
m
 
-cresol induced a
response, whereas prior application of caffeine or chloro-
 
m
 
-cresol blocked IP
 
3
 
-induced Ca
 
2
 
 
 
 release. In cultured
human PASMCs, which lack functional expression of RyRs, caffeine failed to affect ATP-induced increases in
[Ca
 
2
 
 
 
]
 
i
 
 in the presence and absence of extracellular Ca
 
2
 
 
 
. The RyR antagonists ruthenium red, ryanodine, tetracaine,
and dantrolene greatly inhibited submaximal noradrenaline– and hypoxia-induced Ca
 
2
 
 
 
 release and contraction
in freshly isolated rat PASMCs, but did not affect ATP-induced Ca
 
2
 
 
 
 release in cultured human PASMCs. Real-time
quantitative RT-PCR and immunoﬂuorescence staining indicated similar expression of all three RyR subtypes
(RyR1, RyR2, and RyR3) in freshly isolated rat PASMCs. In freshly isolated PASMCs from RyR3 knockout (RyR3
 
 
 
/
 
 
 
)
mice, hypoxia-induced, but not submaximal noradrenaline–induced, Ca
 
2
 
 
 
 release and contraction were signiﬁcantly
reduced. Ruthenium red and tetracaine can further inhibit hypoxic increase in [Ca
 
2
 
 
 
]
 
i
 
 in RyR3
 
 
 
/
 
 
 
 mouse
PASMCs. Collectively, our data suggest that (a) RyRs play an important role in submaximal noradrenaline– and
hypoxia-induced Ca
 
2
 
 
 
 release and contraction; (b) all three subtype RyRs are expressed; and (c) RyR3 gene
knockout signiﬁcantly inhibits hypoxia-, but not submaximal noradrenaline–induced Ca
 
2
 
 
 
 and contractile responses
in PASMCs.
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INTRODUCTION
 
Ca
 
2
 
 
 
 release from the sarcoplasmic/endoplasmic re-
ticulum (SR) through the intracellular Ca
 
2
 
 
 
 channels
inositol 1,4,5-triphosphate receptors (IP
 
3
 
Rs) and RyRs is
critical for numerous cellular responses. The functional
redundancy of these channels substantially complicates
the understanding of the physiological role of RyRs in
vascular smooth muscle cells (SMCs). We have recently
shown that activation of RyRs with caffeine induces
Ca
 
2
 
 
 
 release and prevents subsequent neurotransmitter-
induced responses, and vice versa, in freshly isolated rat
pulmonary artery SMCs (Wang et al., 2003), indicating
that RyRs and IP
 
3
 
Rs may be functionally colocalized
in the same SR. Similar functional colocalization of
both receptors in the same SR has also been found in
cultured rat pulmonary artery smooth muscle cells
(PASMCs) (Zhang et al., 2003) and other types of
vascular myocytes (Leijten and van Breemen, 1984;
Amedee et al., 1990; Pacaud and Loirand, 1995; Boittin
et al., 1999; Janiak et al., 2001). These ﬁndings, together
with the fact that Ca
 
2
 
 
 
 activates RyRs and induces Ca
 
2
 
 
 
release from the SR, a process termed as Ca
 
2
 
 
 
-induced
Ca
 
2
 
 
 
 release (CICR), raise a possibility that Ca
 
2
 
 
 
 released
from IP
 
3
 
Rs may open the neighboring RyRs and then
induce further Ca
 
2
 
 
 
 release, contributing to neuro-
transmitter-induced Ca
 
2
 
 
 
 and contractile responses in
PASMCs. In support of this hypothesis, a recent study
performed in cultured PASMCs has shown that photo-
release of caged IP
 
3
 
 can stimulate RyR-mediated Ca
 
2
 
 
 
sparks (Zhang et al., 2003). However, it should be
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noted that cell culture may signiﬁcantly affect expres-
sion levels and functions of RyRs in vascular SMCs (Ma-
suo et al., 1991; Cortes et al., 1997; Vallot et al., 2000;
Thorne and Paul, 2003).
It is well known that hypoxia exposure induces pul-
monary, but not systemic (mesenteric and cerebral) ar-
tery vasoconstriction (Madden et al., 1992; Vadula et
al., 1993; Yuan et al., 1993; Wang et al., 2003). This
unique hypoxia-induced pulmonary vasoconstriction
serves as an important physiological process for main-
taining arterial oxygenation. We and other investiga-
tors have recently shown that the depletion of SR Ca
 
2
 
 
 
with caffeine (through activation of RyRs) reduces or
abolishes hypoxia-induced increases in [Ca
 
2
 
 
 
]
 
i
 
 and
contraction in PASMCs (Salvaterra and Goldman,
1993; Post et al., 1995; Jabr et al., 1997; Dipp et al.,
2001; Wang et al., 2003). Similarly, ryanodine, an agent
that binds with high afﬁnity to RyRs, largely or com-
pletely inhibits hypoxic responses (Vadula et al., 1993;
Jabr et al., 1997; Dipp et al., 2001; Morio and Mc-
Murtry, 2002). These data suggest that RyRs possi-
bly play an important role in hypoxic responses in
PASMCs.
Three subtypes of RyRs (RyR1, RyR2, and RyR3) are
expressed in mammalian cells, each encoded by dis-
tinct genes. However, studies on mRNA expression of
RyR subtypes in cultured vascular SMCs or vascular tis-
sues have yielded conﬂicting results, showing expres-
sion of RyR1, RyR2, and RyR3 all (Neylon et al., 1995;
Coussin et al., 2000; Lohn et al., 2001), abundant RyR3,
little RyR2, and no RyR1 (Ledbetter et al., 1994; Vallot
et al., 2000), as well as RyR1 only (Vallot et al., 2000).
These conﬂicting data may occur due to the changes in
RyR expression patterns and levels during cell culture
or due to the contamination with other types of cells in
experiments using vascular tissues (Vallot et al., 2000).
Nonetheless, little is known about expression patterns
and levels of RyR subtypes in PASMCs.
Using the antisense oligonucleotide technique to se-
lectively suppress the expression of RyR subtypes, Cous-
sin et al. (2000) have shown that RyR1 and RyR2, but
not RyR3, participate in Ca
 
2
 
 
 
 release following activa-
tion of voltage-dependent Ca
 
2
 
 
 
 currents (I
 
Ca
 
) in cul-
tured portal vein SMCs. However, studies using freshly
isolated portal vein and coronary artery myocytes indi-
cate that I
 
Ca
 
 fails to induce Ca
 
2
 
 
 
 release (Ganitkevich
and Isenberg, 1995; Kamishima and McCarron, 1996).
It has been reported that caffeine- and noradrena-
line-induced arterial muscle contractions are not sig-
niﬁcantly changed in RyR3 knockout (RyR3
 
 
 
/
 
 
 
)
mice (Takeshima et al., 1996). In contrast, a recent re-
port has shown that the frequency of Ca
 
2
 
 
 
 sparks and
STOCs (spontaneous transient outward currents) are
increased in RyR3
 
 
 
/
 
 
 
 mouse cerebral artery myocytes
(Lohn et al., 2001). These discrepancies possibly reﬂect
differential expression patterns and levels of RyR sub-
types in systemic artery SMCs, in addition to different
experimental conditions. Moreover, physiological func-
tions of RyR subtypes in PASMCs are largely unknown.
In the present study, we ﬁrst sought to determine
physiological functions of RyRs in freshly isolated
PASMCs by examining whether these Ca
 
2
 
 
 
 release
channels were involved in noradrenaline- and hypoxia-
induced increases in [Ca
 
2
 
 
 
]
 
i
 
 and contraction using sev-
eral structurally different RyR blockers. Next we exam-
ined mRNA and protein expression patterns and lev-
els of RyR subtypes in freshly isolated PASMCs using
real-time quantitative RT-PCR and immunoﬂuores-
cence staining. Finally, we examined whether RyR3
gene knockout affected noradrenaline- and hypoxia-
induced Ca
 
2
 
 
 
 and contractile responses in freshly iso-
lated PASMCs. Our data indicate that RyRs may amplify
neurotransmitter-induced Ca
 
2
 
 
 
 release and contraction
in PASMCs, which likely occurs through a local IP
 
3
 
R–
RyR interaction. These Ca
 
2
 
 
 
 release channels also play
an important role in hypoxia-induced Ca
 
2
 
 
 
 release and
contraction in PASMCs. All three subtypes of RyRs
are expressed in PASMCs, and the amount of mRNA
transcript is equivalent. RyR3 gene knockout signiﬁ-
cantly inhibits hypoxia-, but not noradrenaline-induced
Ca
 
2
 
 
 
 release and contraction in PASMCs, suggesting a
unique function for this RyR subtype.
 
MATERIALS AND METHODS
 
Cell Preparation
 
Freshly isolated cells were obtained from rat resistance (external
diameter 
 
 
 
 300 
 
 
 
m) pulmonary arteries, since these regional
cells show stronger responses to hypoxia (Madden et al., 1985,
1992; Archer et al., 1996). The procedure for cell isolation was
similar to that described previously (Wang et al., 2003). Under
approved animal care and use protocols, Sprague-Dawley rats
were killed by an intraperitoneal injection of sodium pentobar-
bital (150 mg/kg). Resistance pulmonary arteries were removed
and cleaned of the connective tissue and endothelium. Small
pieces (1
 
   
 
10 mm) of the arteries were incubated in nominally
Ca
 
2
 
 
 
-free physiological saline solution (PSS) containing papain
(Sigma-Aldrich) and dithioerythritol at 37
 
 
 
C for 20 min, then in
nominally Ca
 
2
 
 
 
-free PSS containing type H and II collagenase
(Sigma-Aldrich) and 100 
 
 
 
M Ca
 
2
 
 
 
 for 10–15 min (37
 
 
 
C), and ﬁ-
nally in ice cold nominally Ca
 
2
 
 
 
-free PSS for 15 min. Single cells
were harvested by gentle trituration, and then stored on ice for
use up to 8 h. PSS contained (in mM) 125 NaCl, 5 KCl, 1 MgSO
 
4
 
,
10 HEPES, 1.8 CaCl
 
2
 
, and 10 glucose (pH 7.4).
RyR3 knockout (RyR3
 
 
 
/
 
 
 
) mice were obtained as described
previously (Bertocchini et al., 1997), and maintained as heterozy-
gotes, which were continually backcrossed to generate RyR3
 
 
 
/
 
 
 
and wild-type (RyR3
 
 
 
/
 
 
 
) mice. Freshly isolated resistance (third
and smaller branches) PASMCs from RyR3
 
 
 
/
 
 
 
 and RyR3
 
 
 
/
 
 
 
(same age and sex) mice were prepared using the same proce-
dure as described above.
Cultured human PASMCs were purchased from Cambrex and
cultured in smooth muscle growth medium in a humidiﬁed at-
mosphere of 5% CO
 
2
 
 in air at 37
 
 
 
C. The medium contained 5%
FBS, 0.5 ng/ml human epidermal growth factor, 2 ng/ml human 
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ﬁbroblast growth factor, and 5 
 
 
 
g/ml insulin. Cells at the ﬁfth
and sixth passage were used for experiments.
 
Measurements of Whole-cell [Ca
 
2
 
 
 
]
 
i
 
Measurements of whole-cell [Ca
 
2
 
 
 
]
 
i
 
 were made by a dual excita-
tion wavelength ﬂuorescence method as described previously
(Wang et al., 2003), using the IonOptix ﬂuorescence photometric
system (Milton). PASMCs were loaded with 4 
 
 
 
M fura-2/AM for
20 min. The dye was excited at 340- and 380-nm wavelengths (Xe-
non 75 W arc lamp). The emission ﬂuorescence at 510 nm was de-
tected by a photomultiplier tube. Photo bleaching was minimized
by using neutral density ﬁlters and by shuttering excitation light
between sampling periods. Background ﬂuorescence was deter-
mined by removing the cell from the ﬁeld after the experiment.
 
Membrane Current Recording
 
Whole-cell membrane currents were measured using nystatin-
perforated or standard patch clamp techniques (Wang et al.,
2003) with a patch clamp ampliﬁer (EPC-9; Heka Electronics).
For the perforated patch clamp experiments, patch pipettes
ﬁlled with intracellular solution had a resistance of 2–3 M
 
 
 
. Ny-
statin was included in the pipette solution at a ﬁnal concentration
of 250 
 
 
 
g/ml. When electrical access was detected, cells were
clamped at a holding potential of 
 
 
 
55 mV. Membrane capaci-
tance and series resistance were continuously monitored and
compensated, and experiments initiated following a decrease in
the access resistance to 
 
 
 
40 M
 
 
 
. In some experiments, the stan-
dard whole-cell technique was used to dialyze the tested reagents
into the cell. In this case, the resistance of the patch pipettes was
1–2 M
 
 
 
. The pipette solution contained (in mM) 125 CsCl, 5
NaCl, 1.2 MgCl
 
2
 
, 3 EGTA, 1 CaCl
 
2
 
, and 10 HEPES (pH 7.3) for
perforated patch clamp experiments, and 125 CsCl (or KCl), 5
NaCl, 1.2 MgCl
 
2
 
, 3 ATP-Mg, and 10 HEPES (pH 7.3) for standard
whole-cell recordings.
 
Reverse Transcriptase (RT) PCR
The expression of RyR mRNAs in cultured human PASMCs was
examined using RT-PCR. Total RNAs were isolated using Abso-
lutely RNA Miniprep Kit (Stratagene). One-step RT-PCR was
performed using SuperScript One-Step RT-PCR with Platinum
Taq (Invitrogen) according to the manufacturer’s instructions,
supplemented with the following forward and reverse oligonucle-
otide primers: 5 -GGCTGGTATATGGTGATGTC-3  and 5 -TCG-
CTCTTGTTGTAGAACTTGCGG-3 for human RyR1 gene, 5 -
ACAGCATGGCCCTTTACAAC-3  and 5 -TTGGCTTTCTCTTT-
GGCTGT-3  for human RyR2 gene, and 5 -CTGTCATCTGTAAC-
TCACAA-3  and 5 -GTGTCAAAGTAGTCATTGCCAA-3 for hu-
man RyR3 gene. The ampliﬁed products were electrophoresed
on an agarose gel, stained with ethidium bromide, and visualized
by UV illumination.
For real-time quantitative RT-PCR experiments, freshly iso-
lated rat resistance PASMCs were used to yield total RNAs to
avoid the contamination of neurons, endothelial and other types
of cells. Isolated cells were collected using a Burleigh PCS-5300
manipulator under the help of a Nikon inverted microscope. To-
tal RNAs were obtained using Absolutely RNA Nanoprep Kit
(Stratagene). The ﬁrst-strand cDNAs were synthesized from
RNAs using SuperScript First-Strand Synthesis System for RT-
PCR (Invitrogen). The resultant cDNAs were ampliﬁed by spe-
ciﬁc target gene forward and reverse primers: 5 -TCTTCCCT-
GCTGGAGACTGT-3  and 5 -TGGGAGAAGGCACTTGAGG-3 
for rat RyR1 gene, 5 -ACAACCCAAATGCTGGTCTC-3  and 5 -
TCCGGTTCAGACTTGGTTTC-3  for rat RyR2 gene, and 5 -
CTGGCCATCATTCAAGGTCT-3  and 5 -GTCTCCATGTCTTC-
CCGTA-3  for rat RyR3 gene, with the iQ SYBR Green Supermix
(Bio-Rad Laboratories, Inc.) using an iCycler iQ Real-time PCR
Detection System (Bio-Rad Laboratories, Inc.). The housekeep-
ing gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
was used as endogenous control. To quantify the target gene
mRNA levels, known RyR1, RyR2, RyR3, and GADPH DNAs
were used for constructing standard curves. Known DNAs and
unknown sample cDNAs at series dilutions (1:10) were simulta-
neously ampliﬁed. Real-time PCR was run for one cycle at 95 C
for 3 min followed immediately by 40 cycles at 95 C for 20 s, 58 C
(to be varied with different primers) for 20 s, and 72 C for 20 s.
The ﬂuorescence was measured after each of the repetitive cy-
cles. A melting point dissociation curve generated by the instru-
ment was used to conﬁrm that only a single product was present.
To validate the speciﬁcity, no reverse transcriptase and no tem-
plate control experiments were performed to conﬁrm no ﬂuo-
rescence resulting from either genomic DNA contamination or
PCR step. The PCR ampliﬁcation products were also veriﬁed by
electrophoresis and sequencing analysis. The absolute expres-
sion levels of subtype RyR mRNAs in cells were calculated from
standard curves of known DNAs. The absolute mRNA expression
levels of target genes were also normalized to levels of GADPH
mRNAs to yield the relative levels of target genes.
Immunoﬂuorescence Staining
The experimental protocol was similar to that described previ-
ously (Zhang et al., 2001). In brief, freshly isolated rat PASMCs
were ﬁxed in 4% paraformaldehyde in PSS for 15 min at room
temperature, incubated with 0.2% Triton X-100 in PSS for 30
min, and then blocked for 1 h with 2.5% BSA PSS. After that,
cells were incubated with speciﬁc primary antibody at 4 C over-
night, followed by Alexa488- or Alexa594-conjugated anti-mouse
or anti-rabbit antibody (1:750 dilution) (according to the host
species of primary antibody) for 2 h. Immunoﬂuorescence stain-
ing was examined using Zeiss LSM510 laser scanning confocal
microscope. The z interval was adjusted to 1  m to obtain sufﬁ-
cient ﬂuorescence signals. Alexa488 and Alexa594 were excited
at 488 and 543 nm using a krypton-argon laser, and ﬂuorescence
was detected using 505 and 585-nm bandpass ﬁlters, respectively.
Smooth Muscle Tension Measurements
The third branches of rat or mouse pulmonary arteries were sec-
tioned into segments 3 mm in length, and placed in 2-ml tissue
baths (Radnoti). One end of the muscle strip was ﬁxed to a small
clip, and the other end connected to a highly sensitive force
transducer (Harvard Apparatus). The bath solution contained
(in mM): 110 NaCl, 3.4 KCl, 2.4 CaCl2, 0.8 MgSO4, 25.8 NaHCO3,
1.2 KH2PO4, and 5.6 glucose (pH 7.4), aerated with 20% O2, 5%
CO2, and 75%N2, and warmed at 35 C. The strips were set at a
resting tone of 250 mg. Contractile force was recorded using a
PowerLab/4SP recording system (AD Instruments). In experi-
ments examining noradrenaline-induced muscle contraction,
concentration–response curves were constructed by ﬁtting the
mean values of data with Origin Version 7 software (OriginLab
Corporation), using the nonlinear Boltzmann equation: y  
A2   (A1   A2)/(1   exp((x   x50)/dx)), where A1 was mini-
mal noradrenaline-induced contraction, A2 maximal contrac-
tion, x the logarithm of noradrenaline concentration, x50 the log-
arithm of concentration for half-maximal contraction (EC50),
and dx the slope factor of the curve.
Hypoxia
In experiments using freshly isolated PASMCs, hypoxia was
achieved by switching a perfusing solution from a bath solution430 Role of Ryanodine Receptors in Pulmonary Artery Myocytes
equilibrated with 20% O2, 5% CO2, and balance with N2 (nor-
moxic) to a solution equilibrated with 1% O2, 5% CO2, and bal-
ance with N2 mixtures (hypoxic). For muscle strip experiments,
hypoxia was achieved by switching the bath solution gas mixtures
from 20% O2, 5% CO2, and 75% N2 to 1% O2, 5% CO2, and 94%
N2. The oxygen tension of the solution was continuously moni-
tored by means of an oxygen electrode (OXEL-1, WPI). The bath
Po2 was  140 and 10–20 Torr in the normoxic and hypoxic solu-
tion, respectively (Wang et al., 2000).
Reagents and Antibodies
Alexa488- and Alexa594-conjugated anti-mouse and anti-rabbit
antibodies, as well as fura-2/AM were obtained from Molecular
Probes; IP3 and ruthenium red from Calbiochem; anti-RyR1 anti-
body from Upstate Biotechnology; anti-actin (smooth muscle)
antibody, anti-myosin (smooth) antibody, caffeine, chloro-m-cre-
sol, dantrolene, noradrenaline, nystatin, ryanodine, and tetra-
caine from Sigma-Aldrich. Anti-RyR2 and anti-RyR3 antibodies
were provided by A.F. Lai (University of Wales, Cardiff, UK). The
isoform-speciﬁc RyR antibodies were tested for conﬁrmation of
their speciﬁcity.
Data Analysis
All values were expressed as means   SEM of n samples investi-
gated. Student’s t test was used to determine the signiﬁcance of
differences between two observations, whereas one-way ANOVA
was used for multiple comparisons. A P value of  0.05 was con-
sidered to be signiﬁcant.
RESULTS
Ryanodine Receptors and Inositol Triphosphate Receptors 
Functionally Overlap in PASMCs
Previous studies have shown that activation of RyRs with
caffeine, similar to activation of IP3Rs with noradrena-
line, induces Ca2  release from the SR in freshly iso-
lated canine and rat PASMCs (Janiak et al., 2001; Wang
et al., 2003). Here we sought to compare the extent of
Ca2  release following maximal activation of RyRs and
IP3Rs. Freshly isolated rat PASMCs were loaded with
fura-2/AM and voltage clamped at  55 mV using the
perforated patch clamp technique. Cs  patch pipette
solution was used to block outward K  currents. Under
these conditions, application of caffeine (10 mM) in-
duced an increase in [Ca2 ]i and an inward Ca2 -acti-
vated Cl  current (ICl(Ca)) (Wang et al., 1997b, 2003). A
typical example of these experiments is shown in Fig. 1
A. In a total of 16 cells tested, the mean increase in
[Ca2 ]i was 702   27 nM (from a resting level of 112  
17 to 815   29 nM), and the current had a mean ampli-
tude of 581   42 pA (Fig. 1 B). Stimulation of adrener-
gic receptors with noradrenaline (300  M) to activate
IP3Rs induced Ca2  and current responses with similar
amplitudes to caffeine-induced responses (Fig. 1 A).
The mean increase in [Ca2 ]i following application of
noradrenaline was 674   43 nM, and mean amplitude
of ICl(Ca) was 613   33 pA (n   17) (Fig. 1 B). Thus,
maximal activation of RyRs with caffeine and IP3Rs with
noradrenaline induces equivalent Ca2  release and asso-
ciated ICl(Ca), which is consistent with previous ﬁndings
(Janiak et al., 2001; Wang et al., 2003) and suggests that
RyRs are highly expressed in PASMCs.
Our recent study has shown that prior application
of noradrenaline blocks subsequent caffeine-induced
Ca2  release in freshly isolated rat PASMCs, and vice
versa, indicating that both RyRs and IP3Rs may func-
tionally overlap (Wang et al., 2003). To further test this
view, we examined the effect of IP3 on caffeine-induced
Ca2  release in freshly isolated rat PASMCs. In these ex-
periments, voltage-clamped ( 55 mV) myocytes were
ﬁrst dialyzed with IP3 to induce Ca2  release through
IP3Rs selectively, and then exposed to caffeine. As
shown in Fig. 2 A, dialysis of IP3 induced a Ca2 -acti-
vated Cl  current (Ca2  release). The mean amplitude
of the currents was 507   52 pA (n   5). However, sub-
sequent application of caffeine failed to induce any re-
sponse in all ﬁve cells tested. In converse experiments,
cells were ﬁrst exposed to caffeine and then dialyzed
with IP3. Caffeine-induced Ca2  release was assessed by
examining the activity of single Ca2 -activated K  (KCa)
channels under cell-attached patch clamp conditions,
using K  patch pipette solution. Application of caffeine
(10 mM) caused a burst increase in activity of single KCa
channels in a cell (Fig. 2 B). The mean current ampli-
Figure 1. Activation of ryanodine receptors with caffeine and
inositol triphosphate receptors with noradrenaline induce
equivalent increases in [Ca2 ]i and Ca2 -activated Cl  currents in
freshly isolated rat pulmonary artery smooth muscle cells. (A)
Original recordings show caffeine- and noradrenaline-induced
increases in [Ca2 ]i and ICl(Ca). Both cells were loaded with fura-2/
AM and voltage clamped at  55 mV using the perforated patch
clamp technique. Cs  pipette solution was used to block K 
currents. (B) Summary of caffeine- and noradrenaline-induced
Ca2  and current responses. Numbers in parentheses indicate the
number of cells tested.431 Zheng et al.
tude in a total of ﬁve cells was 23   4 pA. Following the
caffeine response, the cell membrane was ruptured to
obtain the whole-cell patch clamp conﬁguration, and
IP3 (100  M) was dialyzed into the cell through the
patch pipette. However, dialysis of IP3 failed to induce
any current in the continued presence of caffeine.
These results are consistent with our previous ﬁndings
(Wang et al., 2003), further indicating that both RyRs
and IP3Rs functionally overlap in rat PASMCs.
It has been reported that caffeine may inhibit IP3-
induced Ca2 -activated Cl  currents (Ca2  release) in
Xenopus oocytes (Parker and Ivorra, 1991), cerebellum
IP3Rs reconstituted in planar lipid bilayers (Bezproz-
vanny et al., 1994), and IP3-induced Ca2  release in per-
meabilized A7r5 cells in the absence of ATP (Missiaen
et al., 1994). To exclude the possibility that IP3 activity
was blocked by caffeine, we examined the effect of
chloro-m-cresol (CMC), another RyR activator without
reported actions on IP3Rs, on noradrenaline-induced
increase in [Ca2 ]i. Application of CMC (1 mM) in-
duced an increase in [Ca2 ]i in freshly isolated rat
PASMCs. The mean increase in [Ca2 ]i by CMC was
755   67 nM (n   6). In the continued presence of
CMC, however, application of noradrenaline (300  M)
no longer evoked Ca2  release in six cells tested. On
the other hand, application of noradrenaline induced
an increase in [Ca2 ]i with a mean amplitude of 686  
70 nM, and prevented subsequent CMC-induced re-
sponses in seven cells tested.
It is known that cell culture may result in signiﬁcant
changes in RyR expression levels and patterns in vascu-
lar SMCs, as caffeine fails to induce Ca2  release (Masuo
et al., 1991; Cortes et al., 1997; Vallot et al., 2000). Thus,
we sought to utilize the cultured human PASMCs as an
alternative approach to examine if caffeine could in-
hibit neurotransmitter-induced Ca2  release. Applica-
tion of caffeine (10 mM) could not evoke an increase in
[Ca2 ]i in a cultured human PASMC, although subse-
quent application of ATP (100  M) induced a large re-
sponse in the same cell (Fig. 3 A). Similar observations
were obtained from six other cells. Moreover, CMC (1
mM) was also unable to induce any Ca2  release (n  
6). We then examined the expression of RyRs in cul-
tured human PASMCs using RT-PCR. As shown in Fig. 3
B, the PCR products for RyR1, RyR2, and RyR3 genes
Figure 2. Ryanodine receptors and inositol triphosphate recep-
tors are functionally colocalized in freshly isolated rat pulmonary
artery myocytes. (A) In a voltage-clamped ( 55 mV) cell, dialysis
of inositol triphosphate (100  M) evoked a Ca2 -activated Cl 
current (Ca2  release). However, subsequent application of caffeine
(10 mM) failed to induce any further response. (B) On the cell-
attached conﬁguration, application of caffeine (10 mM) induced a
burst increase in the activity of Ca2 -activated K  channels in a cell
(holding potential:  20 mV), indicating Ca2  release. In the
continued presence of caffeine, however, dialysis of inositol
triphosphate (100  M) following membrane rupture was unable
to induce any response (holding potential:  55 mV). K  intracel-
lular solution was used in these experiments. Figure 3. Caffeine does not inhibit ATP-induced increases in
[Ca2 ]i in cultured human pulmonary artery myocytes that lack
functional expression of ryanodine receptors. (A) Original re-
cording shows that application of caffeine (10 mM) could not
induce an increase in [Ca2 ]i in a cultured human PASMC. In the
same cell, however, application of ATP (100  M) evoked a large
response in the continued presence of caffeine. (B) RyR1, RyR2,
and RyR3 mRNAs are detected in cultured human PASMCs by
RT-PCR. Total RNAs were ampliﬁed with oligonucleotide primers
for human RyR1, RyR2, and RyR3 mRNAs, as described in mate-
rials and methods. The PCR products were separated by gel
electrophoresis, stained with ethidium bromide, and visualized by
UV illumination. Predicted sizes of RyR1, RyR2, and RyR3 were
224, 265, and 431 bp, respectively. No product was found if reverse
transcriptase was omitted (No RT). (C) ATP (10  M) induced
increases in [Ca2 ]i in a cell before and after treatment with
caffeine (10 mM).432 Role of Ryanodine Receptors in Pulmonary Artery Myocytes
with the predicted sizes of 224, 265, and 431 bp were
found. These data indicate that cultured human PASMCs
lack responses to RyR agonists, although they express
RyR mRNAs, which are consistent with previous reports
in cultured rat aortic SMCs (Masuo et al., 1991; Cortes
et al., 1997; Vallot et al., 2000).
Using these cultured human myocytes, we examined
the effect of caffeine on neurotransmitter-induced Ca2 
release. As an example shown in Fig. 3 C, application of
ATP (10  M) induced similar increases in [Ca2 ]i in a
cell before and after exposure of caffeine (10 mM) for 5
min. The mean increases in [Ca2 ]i before and after
treatment of caffeine were 378   29 and 398   13 nM,
respectively (P   0.05, n   5). Similarly, ATP-induced
increase in [Ca2 ]i in the absence of extracellular Ca2 
(nominally Ca2 -free bath solution containing 1 mM
EGTA) to prevent Ca2  inﬂux was not affected by treat-
ment with caffeine (10 mM) for 5 min (unpublished
data). These results suggest that caffeine has no in-
hibitory effect on ATP-mediated Ca2  release through
IP3Rs. Taken together, we believe that the failure of no-
radrenaline or IP3 to induce an effect in the presence of
caffeine is not due to the direct inhibition of IP3-medi-
ated Ca2  release. Rather, these data further support the
view that prior application of caffeine to activate RyRs
may deplete SR Ca2 , and then block subsequent IP3-
induced Ca2  release. Thus, RyR- and IP3-sensitive Ca2 
stores appear to overlap functionally in rat PASMCs.
Ryanodine Receptors Amplify Submaximal Neurotransmitter–
induced Ca2  Release and Contraction in PASMCs
The functional colocalization of RyRs and IP3Rs in the
SR, together with the known function of RyRs in medi-
ating Ca2 -induced Ca2  release in SMCs (Imaizumi
et al., 1998; Collier et al., 2000), led us to hypothesize
that Ca2  released from IP3Rs during stimulation of
neurotransmitter receptors might activate neighbor-
ing RyRs, contributing to neurotransmitter-induced re-
sponses. To test this hypothesis, we ﬁrst examined the
effect of the RyR antagonist ruthenium red on nor-
adrenaline-induced increase in [Ca2 ]i in freshly isolated
rat PASMCs. As shown in Fig. 4 A, repeated application
of noradrenaline (10  M) induced consistent increases
in [Ca2 ]i in a control cell. Similar observations were
obtained from eight other cells (Fig. 4 C). In contrast,
noradrenaline induced a smaller increase in [Ca2 ]i in a
cell after treatment with ruthenium red (50  M) for 5
min (Fig. 4 B). The average increases in [Ca2 ]i follow-
ing noradrenaline (10  M) exposure were 436   44 nM
before ruthenium red treatment and 141   17 nM after
ruthenium red treatment (P   0.05, n   10) (Fig. 4 C).
Similarly, pretreatment with the structurally different
RyR antagonists ryanodine (100  M) and tetracaine (10
 M) also signiﬁcantly inhibited submaximal noradrena-
line (10  M)–induced increases in [Ca2 ]i (Fig. 4 C).
However, ruthenium red and tetracaine, unlike ryano-
dine, did not signiﬁcantly affect maximal noradrenaline
(300  M)–induced Ca2  release (Fig. 4 D). Thus, RyRs
may amplify Ca2  release following submaximal stimu-
lation of adrenergic receptors with noradrenaline in
PASMCs, which occurs through the local IP3R–RyR in-
teraction (Ca2 -induced Ca2  release mechanism).
We next examined the effects of RyR antagonists on
noradrenaline-induced muscle contraction in rat pul-
monary artery strips. As shown in Fig. 5, in the pres-
ence of ruthenium red (50  M), ryanodine (100  M),
tetracaine (10  M), or dantrolene (10  M) for 10 min
Figure 4. Ryanodine receptor antagonists inhibit submaximal
noradrenaline–induced increases [Ca2 ]i in freshly isolated rat
pulmonary artery smooth muscle cells. (A) Recording trace shows
that repeated application of noradrenaline (10  M) induced
consistent increases in [Ca2 ]i. Both responses had similar ampli-
tudes. (B) Noradrenaline (10  M) induced increases in [Ca2 ]i in
a cell before and after treatment with ruthenium red (50 mM)
for 5 min. Note that noradrenaline response was smaller after
treatment of ruthenium red. (C) Summary of the effects of ru-
thenium red (RR, 50  M), ryanodine (100  M), and tetracaine
(10  M) on submaximal noradrenaline (10  M)–induced increases
in [Ca2 ]i. *, P   0.05 compared with before treatment with RyR
antagonists (open bar). (D) Graph summarizes the effects of
RyR antagonists on maximal noradrenaline (300  M)–induced
increases in [Ca2 ]i.433 Zheng et al.
to block RyRs, concentration–response curves for nor-
adrenaline-induced muscle contraction were shifted
to the right. Ruthenium red, tetracaine, and dantro-
lene did not affect noradrenaline-induced maximal re-
sponses, while ryanodine reduced the maximum con-
traction. These data further suggest that Ca2  release
following submaximal stimulation of neurotransmitter
receptors is able to open the neighboring RyRs, which
causes further Ca2  release from the SR and then
ampliﬁes neurotransmitter-induced increase in [Ca2 ]i
and associated contraction in PASMCs.
Since RyR antagonists have been reported to inhibit
IP3Rs directly or indirectly (Vites and Pappano, 1992;
Yamazawa et al., 1992; Iino et al., 1994; Tovey et al., 2000;
Zimmermann, 2000; Flynn et al., 2001), we sought to ex-
amine the speciﬁcity of the RyR antagonists on neu-
rotransmitter-induced Ca2  release in cultured human
PASMCs, since these cells lack functional expression of
RyRs (Fig. 3). Application of ATP induced similar in-
creases in [Ca2 ]i in a control cell and a cell pretreated
with ruthenium red (50  M) for 5 min (Fig. 6 A). The
mean increases in [Ca2 ]i by ATP (10  M) were 522  
72 in six control cells and 452   48 nM in six cells pre-
treated with ruthenium red, respectively (P   0.05). Sim-
ilarly, ATP (100  M)-induced increases in [Ca2 ]i were
not affected by ruthenium red (50  M) (Fig. 6 B). More-
over, treatment with ryanodine (100  M) and tetracaine
(10  M) for 5 min had no effect on ATP-induced in-
creases in [Ca2 ]i (Fig. 6 B). These results indicate that
the RyR antagonists block neurotransmitter-induced
Ca2  release and contraction in PASMCs by speciﬁcally
inhibiting RyRs, rather than by affecting IP3Rs.
Ryanodine Receptors Mediate Hypoxia-induced Ca2  Release 
and Contraction in PASMCs
It has been reported that pretreatment with caffeine
and ryanodine can inhibit hypoxic increase in [Ca2 ]i
in PASMCs (Salvaterra and Goldman, 1993; Vadula et
al., 1993; Cornﬁeld et al., 1994; Wang et al., 2003) and
hypoxic vasoconstriction in isolated pulmonary artery
strips and lungs (Jabr et al., 1997; Dipp et al., 2001; Mo-
rio and McMurtry, 2002). Considering that the inhibi-
tory effects of these compounds could occur due to the
depletion of SR Ca2 , we sought to use ruthenium red
and tetracaine, the RyR antagonists that do not open
the channels and deplete SR Ca2 , to examine hypoxic
increase in [Ca2 ]i in freshly isolated rat PASMCs. Fig.
7 A shows examples of hypoxia-induced increase in
[Ca2 ]i in a control cell and a cell pretreated with ru-
thenium red (50  M) for 5 min. Ruthenium red signif-
icantly inhibited hypoxia-induced response. As summa-
rized in Fig. 7 B, hypoxia-induced increases in [Ca2 ]i
were 442   19 nM in control cells and 188   12 nM in
Figure 6. Ryanodine receptor antagonists do not inhibit ATP-
induced increases in [Ca2 ]i in cultured human pulmonary artery
smooth muscle cells. (A) Original recording shows that ATP
(10  M) induced increases in [Ca2 ]i in a control cell and a cell
pretreated with ruthenium red (50  M) for 5 min. (B) Summary
of the effects of ruthenium red (50  M), ryanodine (100  M), and
tetracaine (10  M) on ATP (10 and 100  M)-induced increases in
[Ca2 ]i.
Figure 5. Ryanodine receptor antagonists inhibit noradrenaline-
induced muscle contraction in freshly isolated rat pulmonary
artery strips. Concentration–response curves for noradrenaline-
induced muscle contraction were obtained before and after
treatment of ruthenium red (50  M), ryanodine (100  M),
tetracaine (10  M), or dantrolene (10  M) for 10 min. Data
points represent the mean values of six or seven identical experi-
ments. The continuous lines were curves ﬁtted to a nonlinear
Boltzmann equation (see materials and methods).434 Role of Ryanodine Receptors in Pulmonary Artery Myocytes
ruthenium red–treated cells (n   8, P   0.05). Simi-
larly, pretreatment with ryanodine (100  M) and tetra-
caine (10  M) for 5 min to block RyRs also inhibited
hypoxia-induced increases in [Ca2 ]i (Fig. 7 B). There-
fore, hypoxia may result in the opening of RyRs and
subsequent Ca2  release in PASMCs.
In the next experiments, we investigated the effect of
RyR antagonists on hypoxic vasoconstriction in freshly
isolated rat pulmonary artery strips. In control muscle
strips, repeated hypoxic exposure induced consistent
vasoconstrictions (Fig. 8). However, in muscle strips
pretreated with ruthenium red (50  M) for 10 min,
hypoxic pulmonary vasoconstriction was markedly inhib-
ited. In a total of seven identical experiments, hypoxic
vasoconstrictions were decreased from 170   14 mg be-
fore treatment with ruthenium red to 98   5 mg after
treatment with ruthenium red (P   0.05) (Fig. 8 C).
Similarly, ryanodine (100  M) and tetracaine (10  M)
also signiﬁcantly blocked hypoxic vasoconstrictions. Taken
together, these data suggest that RyRs serve as an im-
portant target for hypoxia, by which these Ca2  release
channels are opened during hypoxic stimulation, con-
tributing to hypoxic increase in [Ca2 ]i and contrac-
tion in PASMCs.
All Three Subtypes of Ryanodine Receptors Are Expressed 
in PASMCs
To further determine expression patterns and levels of
RyR subtype expression in PASMCs, we examined the
expression of RyR1, RyR2, and RyR3 mRNAs in freshly
isolated rat myocytes using real-time quantitative RT-
PCR. Freshly isolated cells were used to avoid potential
contaminations with neuronal, endothelial, and other
types of cells as well as to avoid signiﬁcant changes in
expression patterns and levels of RyRs during cell cul-
ture. To verify that the elongated cells freshly isolated
from pulmonary arteries were SMCs, we examined the
expression of smooth muscle actin and myosin in these
cells using immunoﬂuorescence staining. As expected,
both smooth muscle–speciﬁc markers were expressed
in these cells (Fig. 9 A). Using these cells (PASMCs) as
a source of mRNAs, RyR1, RyR2, and RyR3 were am-
pliﬁed by PCR, indicating the presence of all three
RyR subtype mRNAs in PASMCs. In addition, absolute
mRNA expression levels of RyR subtypes, which were
calculated from standard curves of known DNAs, were
similar. Similarly, there were no differences between
relative mRNA expression levels of all three RyR
subtypes, which were generated by normalizing their
mRNA levels to GADPH mRNA levels (n   8, Fig. 9 B).
The ampliﬁcation products of RyR subtypes were fur-
ther examined by gel electrophoresis. Predicted sizes of
Figure 7. Ryanodine receptor antagonists inhibit hypoxic in-
creases in [Ca2 ]i in freshly isolated rat pulmonary artery smooth
muscle cells. (A) Original recordings show hypoxia-induced
increases in [Ca2 ]i in a control cell and a cell pretreated with
ruthenium red (50  M) for 5 min. (B) Summary of the effects of
ruthenium red (50  M), ryanodine (100  M), and tetracaine
(10  M) on hypoxic responses. *, P   0.05 compared with control
(open bar).
Figure 8. Ryanodine receptor antagonists inhibit hypoxic
vasoconstriction in freshly isolated rat pulmonary artery strips. (A)
Original recordings show that repeated hypoxia induced vasocon-
strictions with similar amplitudes in a pulmonary artery strip. (B)
Hypoxic vasoconstrictions were recorded in a pulmonary artery
strip before and after treatment with ruthenium red (50  M) for
10 min. (C) Summary of the effects of ruthenium red (50  M),
ryanodine (100  M), and tetracaine (10  M) on hypoxic pulmo-
nary vasoconstrictions. *, P    0.05 compared with before
treatment with RyR antagonists (open bar).435 Zheng et al.
the RyR1, RyR2, and RyR3 PCR products were 93, 130,
and 83 bp, respectively (Fig. 9 C). Moreover, sequenc-
ing analysis conﬁrmed that the PCR products matched
the known RyR1, RyR2, and RyR3 mRNA sequences. To
complement mRNA expression patterns of RyR sub-
types, we studied the expression of RyR1, RyR2, and
RyR3 proteins in freshly isolated PASMCs using immu-
noﬂuorescence staining. As examples show in Fig. 9 D,
all RyR1, RyR2, and RyR3 proteins were detected. Simi-
lar observations were made in three or four separate
experiments. These data are consistent with mRNA ex-
pression in PASMCs.
Type-3 Ryanodine Receptors Mediate Hypoxia-induced, 
but not Noradrenaline-induced, Ca2  Release and 
Contraction in PASMCs
Because RyR3 is expressed in PASMCs, we sought to ex-
amine if neurotransmitter-induced Ca2  release was af-
fected in PASMCs from RyR3 /  mice. Fig. 10 A shows
an example of these experiments, in which noradrena-
line (10  M) induced similar increases in [Ca2 ]i in
wild-type (RyR / ) and RyR3 /  mouse PASMCs. The
mean increases in [Ca2 ]i were 358   24 nM in RyR3 / 
PASMCs (n   8) and 331   17 nM in RyR3 /  PASMCs
(n   9) (Fig. 10 B). Similarly, concentration–response
curves for noradrenaline-induced muscle contractions
were not altered in pulmonary artery strips from
RyR3 /  mice (Fig. 10 C).
Next we determined if hypoxia-induced increases in
[Ca2 ]i were altered in RyR3 /  mouse PASMCs. As ex-
Figure 9. All three subtypes of ryanodine receptors are expressed
in freshly isolated rat pulmonary artery smooth muscle cells. (A)
Expression of smooth muscle–speciﬁc actin and myosin in freshly
isolated cells from pulmonary arteries was examined by us-
ing immunoﬂuorescence staining. Both smooth muscle–speciﬁc
markers were present in these cells, further conforming that these
cells were PASMCs. (B) RyR1, RyR2, and RyR3 mRNA expression
was examined by using real-time quantitative RT-PCR. Total RNAs
were obtained from freshly isolated rat PASMCs. Absolute mRNA
levels of RyR subtypes (left) were calculated from standard curves
of known DNAs. Relative mRNA levels (right) were generated by
normalizing RyR subtype mRNA levels to GADPH mRNA levels
(n   8). (C) The RyR1, RyR2, and RyR3 PCR products were
verified by gel electrophoresis. Predicted sizes of GAPDH, RyR1,
RyR2, and RyR3 were 87, 93, 130, and 83 bp, respectively. No
product was detected if reverse transcriptase was omitted (No RT).
(D) Examination of RyR1, RyR2, and RyR3 protein expression
using immunoﬂuorescence staining. RyR subtypes were probed
with speciﬁc anti-RyR1, anti-RyR2, and anti-RyR3 antibodies.
Images were taken using a Carl Zeiss MicroImaging, Inc. LSM510
confocal microscope.
Figure 10. Type-3 ryanodine receptor gene knockout does
not affect submaximal noradrenaline–induced Ca2  release and
contraction in freshly isolated mouse pulmonary artery myocytes.
(A) Original recordings show noradrenaline (10  M)-induced
increases in [Ca2 ]i in a pulmonary artery myocyte from wild-type
(RyR3 / ) and RyR3 /  mouse. (B) Summary of noradrenaline
(10  M)-induced Ca2  responses in PASMCs from RyR3 /  and
RyR3 /  mice. (C) Graph shows concentration–response curves
for noradrenaline-induced muscle contraction in pulmonary artery
strips from RyR3 /  and RyR /  mice.436 Role of Ryanodine Receptors in Pulmonary Artery Myocytes
amples show in Fig. 11 A, hypoxia-induced increase in
[Ca2 ]i was signiﬁcantly smaller in RyR3 /  than that
in RyR3 /  PASMCs. The mean hypoxia-induced in-
creases in [Ca2 ]i were decreased from 379   25 nM in
wild-type cells (n   12) to 200   11 nM in RyR3 / 
cells (n   19, P   0.05) (Fig. 11 B). To test the poten-
tial role of other RyR subtypes in hypoxic response, we
studied the effect of the RyR antagonists ruthenium
red and tetracaine on hypoxic increase in [Ca2 ]i in
freshly isolated PASMCs from RyR3 /  mice. Pretreat-
ment with ruthenium red (50  M) for 5 min signiﬁ-
cantly inhibited hypoxic increase in [Ca2 ]i in RyR3 / 
PASMCs. The mean hypoxic increases in [Ca2 ]i in
RyR3 /  cells un-pretreated (n   30) and pretreated
with ruthenium red (n   24) were 220   10 and 101  
11 nM, respectively (P   0.05). Similarly, pretreatment
with tetracaine (10  M) for 5 min could also inhibit
hypoxic response in RyR3 /  PASMCs (Fig. 11 C). Con-
sistent with the reduced hypoxic increase in [Ca2 ]i
in RyR3 /  PASMCs, hypoxic pulmonary vasoconstric-
tion in RyR3 /  mice was signiﬁcantly inhibited. As
summarized in Fig. 11 D, hypoxia-induced muscle ten-
sion was 25   3 mg in RyR3 /  pulmonary artery strips
(n   8) and 37   4 mg in RyR3 /  pulmonary artery
strips (n   7) (P   0.05). Collectively, these results in-
dicate that RyR3 mediates hypoxia-, but not noradrena-
line-induced Ca2  release in pulmonary artery myo-
cytes. Moreover, RyR1 and/or RyR2 may also play a
role in hypoxic response in PASMCs.
DISCUSSION
We and other investigators have recently demonstrated
that prior application of caffeine to deplete SR Ca2  by
opening RyRs prevents subsequent neurotransmitter-
induced Ca2  release through IP3Rs, and vice versa, in
freshly isolated and cultured rat PASMCs (Wang et al.,
2003; Zhang et al., 2003), suggesting that RyRs and IP3Rs
are functionally coupled in the SR. Consistent with this
view, this study has demonstrated that dialysis of IP3 to di-
rectly activate IP3Rs induces Ca2  release (Ca2 -activated
Cl  currents) and blocks subsequent caffeine responses
in freshly isolated rat PASMCs (Fig. 2 A). Conversely,
prior application of caffeine to induce Ca2  release abol-
ishes subsequent IP3-induced responses (Fig. 2 B).
It has been previously noted that caffeine inhibits IP3-
induced Ca2 -activated Cl  currents (Ca2  release) in
Xenopus oocytes, cerebellar IP3Rs reconstituted in pla-
nar lipid bilayers, and IP3-induced Ca2  release in per-
meabilized A7r5 cells in the absence of ATP by affecting
the binding of IP3 to IP3Rs (Parker and Ivorra, 1991;
Bezprozvanny et al., 1994; Missiaen et al., 1994), al-
though other investigators have shown that caffeine
does not have an effect on the binding of IP3 to its re-
ceptor (Brown et al., 1992; Toescu et al., 1992; McNulty
and Taylor, 1993). To determine whether the failure of
noradrenaline or IP3 to induce Ca2  release following
prior application of caffeine simply reﬂects an inhibi-
tory effect on IP3Rs, we examined the effect of CMC,
another RyR activator that has not been reported to in-
hibit IP3Rs, on noradrenaline-induced Ca2  release in
freshly isolated rat PASMCs. Similar to caffeine, CMC
also induces a large increase in [Ca2 ]i and blocks sub-
sequent noradrenaline-induced Ca2  release. As an-
other approach to examine the speciﬁcity of caffeine as
a selective agonist of RyRs in PASMCs, we performed
experiments in cultured human PASMCs, since cell cul-
ture may result in signiﬁcant changes in RyR expression
levels and patterns in vascular SMCs, in which caffeine
Figure 11. Type-3 ryanodine receptor gene knockout signiﬁ-
cantly inhibits hypoxic increase in [Ca2 ]i and contraction in
freshly isolated mouse pulmonary artery myocytes. (A) Original
recordings show hypoxic increases in [Ca2 ]i in a pulmonary
artery myocyte from RyR3 /  and RyR3 /  mouse. (B) Summary
of hypoxia-induced Ca2  responses in PASMCs from RyR3 /  and
RyR3 /  mice. *, P   0.05 compared with RyR3 / . (C) Graph
summarizes hypoxic increases in [Ca2 ]i in RyR3 /  mouse
PASMCs pretreated without (control) and with ruthenium red
(RR, 50  M) or tetracaine (10  M) for 5 min. *, P   0.05 compared
with control. (D) Summary of hypoxic vasoconstrictions in pul-
monary artery strips from RyR3 /  and RyR3 /  mice. *, P   0.05
compared with RyR3 / .437 Zheng et al.
is ineffective (Masuo et al., 1991; Cortes et al., 1997; Val-
lot et al., 2000). Consistent with these data, we have
found that the RyR agonists caffeine and CMC both fail
to induce Ca2  release, although RyR1, RyR2, and RyR3
mRNAs are found in cultured human PASMCs. In addi-
tion, caffeine does not inhibit ATP-induced increases in
[Ca2 ]i in these cultured cells in the presence and ab-
sence of extracellular Ca2 . These ﬁndings, together
with the fact that application of ATP to stimulate
purinergic receptors can induce Ca2  release through
IP3Rs, although also trigger Ca2  inﬂux through nonse-
lective cation channels in a variety of cells including vas-
cular SMCs (Tawada et al., 1987; Lagaud et al., 1996;
North and Barnard, 1997; Szado et al., 2003), indicate
that caffeine has no inhibitory effect on IP3-mediated
Ca2  release. Taken together, our data indicate that the
failure of noradrenaline and IP3 to induce Ca2  release
in freshly isolated rat PASMCs in the presence of caf-
feine is not due to the inhibition of IP3Rs, but rather
due to prior depletion by caffeine of SR Ca2  stores,
where RyRs and IP3Rs functionally overlap. In support
of this view, direct measurements of SR Ca2  have
shown that caffeine and muscarinic receptor agonists
cause identical patterns of SR Ca2  depletion in gastric
SMCs (White and McGeown, 2002). The reasons for
the different effects of caffeine on IP3-induced Ca2  re-
lease reported by different investigators are unknown,
but they may be related to different experimental con-
ditions. For example, caffeine signiﬁcantly inhibits IP3-
induced Ca2  release in the absence of ATP, but not in
the presence of 1.5 and 5 mM ATP (McNulty and Tay-
lor, 1993; Missiaen et al., 1994). In addition, different
cell types may show different responses to caffeine. It is
known that Xenopus oocytes only express type-1 IP3Rs
(Parys et al., 1992), whereas vascular myocytes (e.g.,
PASMCs) express all three subtypes of IP3Rs (type 1, 2,
and 3 IP3Rs) (Zheng et al., 2004). Thus, the differences
in expression patterns and levels of IP3R subtypes may
also contribute to differential effects of caffeine on IP3-
induced Ca2  release. This may be the case in some
smooth muscle cells and species. In agreement with this
view, a well-designed study using canine PASMCs has
shown the functionally distinct IP3- and ryanodine-sen-
sitive Ca2  stores (Janiak et al., 2001). Similar observa-
tion has been also observed in rabbit and guinea pig co-
lonic SMCs (Young et al., 1999; Flynn et al., 2001).
The functional roles of RyRs have not been well es-
tablished in vascular SMCs. In this study, we have found
that full activation of RyRs with caffeine and IP3Rs with
noradrenaline induce equivalent Ca2  release in rat
PASMCs (Fig. 1), suggesting that RyRs are highly ex-
pressed. Prior application of the structurally different
RyR antagonists ruthenium red, ryanodine, and tetra-
caine can signiﬁcantly inhibit submaximal noradrena-
line–induced increases in [Ca2 ]i. Consistent with these
results, these RyR antagonists shift concentration–
response curves for noradrenaline-induced contraction
to the right. These results suggest that Ca2  released
from IP3Rs following submaximal agonist stimulation
may open neighboring RyRs and then induce further
Ca2  release from the SR (CICR), which ampliﬁes ago-
nist-induced increase in [Ca2 ]i and contraction in
PASMCs. Since it has been reported that RyR antago-
nists may inhibit IP3Rs directly or indirectly (Vites and
Pappano, 1992; Yamazawa et al., 1992; Iino et al., 1994;
Tovey et al., 2000; Zimmermann, 2000; Flynn et al.,
2001), one might argue that the inhibition of IP3Rs
could account for the effects of the RyR antagonists on
noradrenaline-induced Ca2  release and contraction in
PASMCs. However, our data and previous reports indi-
cate that this may not be the case in pulmonary artery
(vascular) SMCS. First, none of the RyR antagonists ru-
thenium red, tetracaine, and dantrolene affect maxi-
mal noradrenaline–induced increase in [Ca2 ]i and cell
contraction (Figs. 4 and 5). Second, ruthenium red,
ryanodine, and tetracaine do not block ATP (10 and
100  M)-induced increases in [Ca2 ]i in the presence
and absence of extracellular Ca2  in cultured human
PASMCs that lack functional expression of RyRs (Fig.
6). Third, recent studies have shown that dialysis of RyR
antibody blocks Ca2  release following stimulation of
 -adrenergic receptors with noradrenaline in cultured
portal vein SMCs (Boittin et al., 1999), and the IP3R an-
tagonists xestospongin C and 2-aminoethoxydiphenyl
inhibit RyR-generated Ca2  sparks in portal vein myo-
cytes (Gordienko and Bolton, 2002). Finally, photore-
lease of caged IP3 can induce Ca2  sparks in cultured
PASMCs (Zhang et al., 2003). Taken together, the RyR
antagonists may block neurotransmitter-induced Ca2 
release and contraction in PASMCs by speciﬁcally inhib-
iting RyRs, rather than by affecting IP3Rs.
It is known that ryanodine concentrations  10  M
activate RyRs, whereas concentrations  10  M block
RyRs in isolated SR preparations (Meissner, 1986). We
have found that ryanodine at 100  M, unlike the other
RyR antagonists ruthenium red, tetracaine, and dan-
trolene, inhibits maximal noradrenaline–induced Ca2 
release and associated contraction in PASMCs (Figs. 5
and 6). These results suggest that following application
of ryanodine (100  M), this agent may initially activate
RyRs possibly due to the low concentration, causing
partial depletion of SR Ca2 .
Several studies have shown that ryanodine inhib-
its hypoxia-induced increases in [Ca2 ]i in cultured
PASMCs and hypoxic pulmonary vasoconstriction in
isolated pulmonary artery and lung preparations (Vad-
ula et al., 1993; Cornﬁeld et al., 1994; Jabr et al., 1997;
Morio and McMurtry, 2002), indicating that RyRs po-
tentially play an important role in hypoxic responses.
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(Figs. 5 and 6), we sought to examine the effects of ru-
thenium red and tetracaine (the RyR antagonists with-
out affecting the SR Ca2 ) on hypoxic responses. As
shown in Fig. 7, prior application of ruthenium red and
tetracaine, similar to ryanodine, also inhibit hypoxia-
induced increases in [Ca2 ]i in PASMCs. Consistent with
these results, hypoxic pulmonary vasoconstriction is
also signiﬁcantly inhibited in pulmonary artery strips
pretreated with ruthenium red, tetracaine, and ryano-
dine. Therefore, RyRs may be important targets for
hypoxia, by which Ca2  release from the SR contrib-
utes to hypoxic increase in [Ca2 ]i and contraction in
PASMCs.
Several studies using RT-PCR have reported that all
three RyR subtype mRNAs are expressed in aorta, cere-
bral, and mesenteric arteries as well as portal vein (Ney-
lon et al., 1995; Coussin et al., 2000; Lohn et al., 2001).
In contrast, other groups have shown that abundant
RyR3, little RyR2, and no RyR1 mRNAs are present in
aorta (Ledbetter et al., 1994; Vallot et al., 2000). More-
over, a recent study has reported that RyR1 mRNA is
present in aorta with endothelium, but not in the tissue
free of endothelium (Vallot et al., 2000). These con-
ﬂicting data in systemic artery SMCs possibly occur due
to changes in expression patterns and levels of RyR sub-
type mRNAs resulting from cell culture and/or due
to the contamination with nonmuscle cells in experi-
ments using vascular tissues (Vallot et al., 2000). Fur-
thermore, there have been no reports aimed at ex-
amining mRNA expression of RyR subtypes in pulmo-
nary artery myocytes. Therefore, we sought to examine
mRNA expression of RyR subtypes in freshly isolated
rat PASMCs using real-time quantitative RT-PCR. As
shown in Fig. 9 B, all three RyR subtype mRNAs are ex-
pressed in freshly isolated rat PASMCs with similar ex-
pression levels. Consistent with mRNA expression, im-
munoﬂuorescence staining experiments using speciﬁc
anti-RyR1, anti-RyR2, and anti-RyR3 antibodies indicate
that all three subtype RyR proteins are expressed in
PASMCs (Fig. 9 D). In support of our ﬁndings, Zhang
et al. (2003) have recently shown that RyR1 and RyR2
proteins are detected in cultured pulmonary artery
myocytes by immunoﬂuorescence staining, although a
nonspeciﬁc anti-RyR2 antibody was used and RyR3 pro-
tein expression was not examined in their study.
RyR3 /  mice have apparently normal growth and re-
production, but show a reduction in neonatal skeletal
muscle contraction, an increase in locomotor activity, as
well as an impairment of hippocampal synaptic plastic-
ity and spatial learning (Takeshima et al., 1996; Bertoc-
chini et al., 1997; Balschun et al., 1999). A study using
cerebral artery myocytes from RyR3 /  mice has re-
vealed that the frequency of Ca2  sparks and STOCs
(spontaneous transient inward currents) are increased
(Lohn et al., 2001), whereas another report has shown
that caffeine- and noradrenaline-induced muscle con-
tractions are not signiﬁcantly changed in RyR3 / 
mouse aortic arteries (Takeshima et al., 1996). In this
study, we have found that submaximal noradrenaline–
induced increases in [Ca2 ]i are similar in PASMCs
from RyR3 /  and RyR3 /  mice. In parallel, concen-
tration–response curves for noradrenaline-induced
muscle contraction are unaffected in pulmonary artery
strips from RyR3 /  mice (Fig. 10 C). In contrast, hyp-
oxia-induced increase in [Ca2 ]i is signiﬁcantly smaller
in PASMCs from RyR3 /  mice than from RyR3 / 
mice. Similarly, hypoxic pulmonary vasoconstriction is
also signiﬁcantly inhibited in RyR3 /  mice (Fig. 11). It
is evident that RyR3 plays an important role in hypoxia-
induced, but not neurotransmitter-induced, Ca2  re-
lease and contraction in PASMCs. This fact, together
with previous ﬁndings that hypoxic increase in [Ca2 ]i
and vasoconstriction are unique cellular responses in
pulmonary, but not systemic (mesenteric and cerebral),
arteries (Madden et al., 1992; Vadula et al., 1993; Yuan
et al., 1993; Wang et al., 2003), suggests that distinct
patterns and/or levels of RyR3 expression between
PASMCs and cells from the systemic circulation might
account for the known differences in the response to
hypoxia in these different arterial beds, although fur-
ther experiments are required to conﬁrm this view.
Our data indicate that the RyR antagonists ruthe-
nium red and tetracaine can further, but not com-
pletely block hypoxic increase in [Ca2 ]i in RyR3 / 
mouse PASMCs (Fig. 11C). This provides evidence that
other RyR subtypes (RyR1 and/or RyR2) as well as ad-
ditional mechanisms may also be involved in hypoxic
responses in PASMCs. In reality, it is well established
that hypoxia can block voltage-dependent K  channels
(Post et al., 1992, 1995; Archer et al., 1993, 1998; Yuan
et al., 1993; Wang et al., 1997a; Hulme et al., 1999), in-
hibit Ca2 /Na  exchanger (Wang et al., 2000), and ac-
tivate capacitative Ca2  entry in PASMCs (Fantozzi et
al., 2003; Lin et al., 2004; Ng et al., 2005). The blockade
of voltage-dependent K  channels by hypoxia depolar-
izes cell membrane, which may presumably activate
voltage-dependent Ca2  channels and then cause Ca2 
inﬂux across cell membrane. The hypoxic inhibition of
Ca2 /Na  exchanger can prevent intracellular Ca2 
removal, contributing to hypoxic increase in [Ca2 ]i.
Thus, it is apparent that multiple pathways of Ca2  re-
lease, entry, and removal are likely to be responsible for
hypoxic increase in [Ca2 ]i and associated contraction
in PASMCs.
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